FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
BioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR9.26, EUR1.14 better than the analyst estimate of EUR8.12. Revenue for the quarter came in at EUR4.28 billion versus the consensus estimate of EUR3.78 billion.
GUIDANCE:
Estimated BioNTech COVID-19 vaccine revenues for the 2023... More

